Amgen Licenses Astellas-Partnered AMG 337 To NantPharma
This article was originally published in Scrip
Executive Summary
NantPharma LLC, a subsidiary of Patrick Soon-Shiong's NantWorks LLC empire, licensed AMG 337 outside of Japan, Russia and other central Asian countries from Amgen Inc., which previously partnered with Astellas Pharma Inc. to develop the cancer drug and four other compounds in certain Asia territories.